- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| 19.03. | The Pebble Group - Well placed for market improvement | 338 | The Pebble Group's FY24 results were broadly in line with January's trading update, with revenue up 1% and a nudge up in gross and adjusted EBITDA margins. This was achieved despite difficult underlying... ► Artikel lesen | ||
| 19.03. | Softcat - H125 results outperform again | 333 | The Softcat machine rolls on. H125 results provide no hint of UK economic and geopolitical uncertainty. Gross profit per customer grew by 10.7% to £43.1k and the customer base expanded by 1.4%, to 10.3k.... ► Artikel lesen | ||
| 19.03. | abrdn UK Smaller Companies Growth Trust - Confirmation that trust is back to winning ways | 351 | abrdn UK Smaller Companies Growth Trust (AUSC) is managed by Abby Glennie and Amanda Yeaman, who are encouraged by the trust's relative performance versus both the reference index, which bottomed in... ► Artikel lesen | ||
| 19.03. | SIGA Technologies - Entering a crucial period for business outlook | 324 | SIGA Technologies reported another year of top-line growth in FY24, with performance weighted to Q4, driven by material TPOXX deliveries to both domestic and international markets. Product revenue grew... ► Artikel lesen | ||
| 19.03. | Boku - Accelerating growth outlook | 264 | Boku reported FY24 revenue growth of 20% and adjusted EBITDA growth of 22%. While direct carrier billing (DCB) maintained double-digit growth, revenue from other local payment methods (LPMs) grew 56%... ► Artikel lesen | ||
| 19.03. | 1Spatial - Transition to software and Saas continues | 381 | 1Spatial's FY25 trading update indicates that the company's transition to a higher-margin, recurring software business continues to make solid progress, with term licence and SaaS revenues up over 35%... ► Artikel lesen | ||
| 19.03. | Centaur Media - Business review underway | 325 | Centaur Media's full year results are broadly in line with January's trading update, with revenue from continuing operations down 6% on the prior year. Adjusted EBITDA came in slightly better than anticipated... ► Artikel lesen | ||
| 18.03. | Computacenter - FY24 results reveal a story of contrasts | 471 | After 19 years of uninterrupted EPS growth, Computacenter's (CCC's) adjusted diluted EPS fell by 8.5% to 159.9p/share in FY24. CCC believes this result masks the fact that H224 was 'the most profitable... ► Artikel lesen | ||
| 18.03. | Sylvania Platinum - Strong FY26 EPS lift as chromite JV kicks in | 599 | Sylvania Platinum's H125 results provided insightful disclosure around the Thaba joint venture (JV) accounting treatment and guidance on the outlook. We have taken the opportunity to recalibrate our... ► Artikel lesen | ||
| 18.03. | The Biotech Growth Trust - Access to major innovation at low valuations | 317 | The Biotech Growth Trust's (BIOG's) highly experienced managers, Geoff Hsu and Josh Golomb, are able to draw on the considerable resources of global healthcare specialist OrbiMed. BIOG's performance... ► Artikel lesen | ||
| 18.03. | Trustpilot (LSE: TRST) continues gaining ground | 366 | Trustpilot's full-year results were as signalled in its January update, with revenue ahead by 18%, delivering an adjusted EBITDA figure in excess of what the market was then forecasting. Margin improvement... ► Artikel lesen | ||
| 18.03. | Eagle Eye Solutions - Partner stimulus | 263 | Eagle Eye Solutions is transitioning to a SaaS business model, which, combined with weak underlying consumer markets, is affecting short-term prospects. To focus on this, though, is to miss the bigger... ► Artikel lesen | ||
| 17.03. | Wheaton Precious Metals - Q424/FY24 results | 583 | Wheaton's adjusted EPS for Q424 exceeded our prior expectations by 1.9%, largely due to better average realised prices for its precious metals. As a consequence, it recorded record revenue, record adjusted... ► Artikel lesen | ||
| 14.03. | Sareum Holdings - New fund-raise and licence signal active 2025 | 366 | Sareum Holdings has announced the acquisition of the licence for SRA737, a checkpoint kinase 1 (CHK1) inhibitor, in which the company had previously held a 27.5% economic interest. Following this acquisition... ► Artikel lesen | ||
| 14.03. | OUTsurance - 52% increase in H125 earnings | 349 | OUTsurance released H125 results on 14 March 2025, delivering 52% normalised EPS growth and return on equity (RoE) of 30.8%. South Africa (SA) property & casualty (P&C) delivered 32% earnings and 9%... ► Artikel lesen | ||
| 14.03. | Basilea (SIX: BSLN) bags a US$2.5m milestone payment | 380 | Basilea has announced another milestone payment from its license partner Pfizer in the Asia Pacific region and China for strong Cresemba sales. Notably, the US$2.5m milestone payment is the first of... ► Artikel lesen | ||
| 12.03. | 4imprint Group - Resilience in uncertain markets | 482 | 4imprint's results are in line with January's trading update, showing a resilient performance in continued challenging markets. The group has attractive cash conversion characteristics and cash had... ► Artikel lesen | ||
| 12.03. | OSE Immunotherapeutics - Tedopi shows promise in pancreatic cancer | 309 | OSE Immunotherapeutics has reported positive top-line data from the investigator-sponsored Phase II trial assessing Tedopi in combination with FOLFIRI (a three-drug chemotherapy regimen made up of folinic... ► Artikel lesen | ||
| 12.03. | CLIQ Digital - Potential public tender | 1.009 | CLIQ Digital has announced that it is considering de-listing its shares. This would partially be effected by a potential tender offer by Dylan Media, a privately owned Dutch investment company funded... ► Artikel lesen | ||
| 12.03. | Cantargia (OMX: CANTA) enrols first patient in leukaemia study | 310 | Cantargia has confirmed that the first patient has been in enrolled in the study assessing nadunolimab in leukaemia. More specifically, this is an investigator-initiated, open-label, Phase Ib/IIa clinical... ► Artikel lesen | ||
| 12.03. | IRLAB (OMX: IRLAB-A) publishes preclinical mesdopetam data in journal | 371 | IRLAB Therapeutics has announced the publication of preclinical data on mesdopetam in the prestigious peer-reviewed journal, European Journal of Neuroscience. The research provided insights into the... ► Artikel lesen | ||
| 12.03. | Tinexta - Strong rebound expected in FY25 | 433 | Tinexta's management is likely happy to have said goodbye to a year in which numerous challenges in two divisions, Business Innovation (BI) and Cyber Security (CS), weighed on group performance. Management... ► Artikel lesen | ||
| 11.03. | Foxtons Group - Strong results; expect growth update at Q2 CMD | 289 | Foxtons Group's FY24 results showed revenue and adjusted operating profit growth of c 11% and c 38%, respectively, reflecting the developing success of the company's strategic vision. This suggests... ► Artikel lesen | ||
| 11.03. | Studio Stays Hotel Group - Hotels with a difference | 263 | From a standing start, the management of Studio Stays Hotel Group (SSHG) aims to gradually acquire a number of good-quality (three- or four-star ratings) but underperforming (ie low occupancy) hotels... ► Artikel lesen | ||
| 11.03. | The London Tunnels - Making good progress | 311 | The London Tunnels' (TLT's) management has made good progress, achieving what they targeted at the time of share listing in Amsterdam in July 2024. These included obtaining the required planning permission... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .